Drug Trial Radar · NCT05953506
Phase 1a Study in Healthy Participants
Last checked: Nov 19, 2026Latest source record: Jul 20, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
52
Planned (sponsor's estimate)
Start
Jul 17, 2023
Primary completion
Dec 24, 2023
Study completion Dec 24, 2023
Sponsor
- Lead sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 20, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral HS-10506 in Chinese Healthy Subjects.
Conditions
- Healthy
Interventions
HS-10506Drug
HS-10506 will be administered orally once on Day 1.
HS-10506 PlaceboDrug
Matching placebo will be administered orally once on Day 1.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of adverse events (AEs), serious adverse events (SAEs) and adverse events leading to discontinuation from the study, and their correlation with the investigational drugTime frame: Screening until Trail phase (up to 5 weeks)
- Number of participants with clinically significant change from baseline in vital signsTime frame: From baseline to Day 3
- Number of participants with clinically significant abnormalities in physical examinationTime frame: From baseline to Day 3
- Changes in 12-lead electrocardiogram from before to after dosingTime frame: From baseline to Day 3
- Change in Stanford Sleepiness Scale score from before to after dosingTime frame: From baseline to 4 hours after dosing
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.